Apex Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Apex Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$28.7M	Buy	678,284 +49,641	+8%	+$2.53M	0.63%	64
2015 Q4	$49.4M	Buy	628,643 +465,650	+286%	+$26.9M	1.1%	34
2015 Q3	$6.6M	Buy	162,993 +17,362	+12%	+$920K	0.15%	126
2015 Q2	$7.58M	Buy	145,631 +13,561	+10%	+$675K	0.16%	121
2015 Q1	$6.14M	Buy	132,070 +35,195	+36%	+$1.83M	0.14%	134
2014 Q4	$4.35M	Buy	96,875 +23,144	+31%	+$972K	0.12%	148
2014 Q3	$2.87M	Buy	+73,731	New	+$2.89M	0.09%	162

Other funds holding ISEE

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JCG

JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Apex Capital Management's ISEE Position: Q1 2016 in Review

Apex Capital Management increased its IVERIC bio, Inc. Common Stock (ISEE) stake by 7.9% in Q1 2016, buying an estimated $2.53M and bringing the position to 678,284 shares worth $28.7M. The position accounts for 0.63% of the portfolio, ranked #64.

Apex Capital Management first reported a position in ISEE in Q3 2014 and has held it in 7 quarters since. The position peaked at $49.4M in Q4 2015. 162 funds tracked by Wall St. Rank hold ISEE as of Q1 2016.

Apex Capital Management held 678,284 shares of IVERIC bio, Inc. Common Stock worth $28.7M as of Q1 2016.
Apex Capital Management bought 49,641 IVERIC bio, Inc. Common Stock shares in Q1 2016, an estimated $2.53M.
IVERIC bio, Inc. Common Stock made up 0.63% of Apex Capital Management's portfolio in Q1 2016, its #64 holding.
Apex Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q3 2014 and has held it in 7 quarters since.
Apex Capital Management's IVERIC bio, Inc. Common Stock position peaked at $49.4M in Q4 2015.
162 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.